Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice

British Journal of Pharmacology

Volumn 163, Issue 5, 2011, Pages 974-983

  Stegbauer, J ^a,c   Potthoff, S A ^a   Quack, I ^a   Mergia, E ^b   Clasen, T ^a   Friedrich, S ^a   Vonend, O ^a   Woznowski, M ^a   Konigshausen E ^a   Sellin, L ^a   Rump, L C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

angiotensin II; angiotensin (1 7); apolipoproteinE knockout mouse; endothelial dysfunction; NO bioavailability; reactive oxygen species

Indexed keywords

8 ISOPROSTANE; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; APOLIPOPROTEIN E; CARBACHOL; CHOLESTEROL; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR; HIGH DENSITY LIPOPROTEIN; HYDROGEN PEROXIDE; LOW DENSITY LIPOPROTEIN; MAS RECEPTOR; NITRATE; NITRIC OXIDE; NITRITE; PROTEIN P22; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SODIUM CHLORIDE; TEMPOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL FUNCTION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FAT INTAKE; GLOMERULUS; ISOLATED KIDNEY; KIDNEY BLOOD VESSEL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TREATMENT DURATION; VASODILATATION;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HYDROGEN PEROXIDE; INFUSION PUMPS, IMPLANTABLE; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; PEPTIDE FRAGMENTS; PERFUSION; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; VASODILATION;

EID: 79958774954     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01295.x     Document Type: Article

References (40)

1. Alexander, SPH, Mathie, A, Peters, JA, (2009). Guide to Receptors and Channels (GRAC), 4th Edition. Br J Pharmacol 158 (Suppl. 1): S1-254.
2. Arruda RM, Peotta VA, Meyrelles SS, Vasquez EC, (2005). Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. Hypertension 46: 932-936.
3. Benter IF, Yousif MH, Dhaunsi GS, Kaur J, Chappell MC, Diz DI, (2008). Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol 28: 25-33. (Pubitemid 350126490)
4. Brooker G, Harper JF, Terasaki WL, Moylan RD, (1979). Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res 10: 1-33.
5. Cai H, Harrison DG, (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844.
6. Castro CH, Santos RA, Ferreira AJ, Bader M, Alenina N, Almeida AP, (2005). Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension 46: 937-942.
7. Costa MA, Lopez Verrilli MA, Gomez KA, Nakagawa P, Pena C, Arranz C, et al,. (2010). Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 299: H1205-H1211.
8. Custodis F, Baumhakel M, Schlimmer N, List F, Gensch C, Bohm M, et al,. (2008). Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 117: 2377-2387. (Pubitemid 351653554)
9. Doran DE, Weiss D, Zhang Y, Griendling KK, Taylor WR, (2007). Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species. Atherosclerosis 195: 39-47. (Pubitemid 47561942)
10. d'Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, et al,. (2001). Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21: 1017-1022. (Pubitemid 34168662)
11. Faria-Silva R, Duarte FV, Santos RA, (2005). Short-term angiotensin(1-7) receptor MAS stimulation improves endothelial function in normotensive rats. Hypertension 46: 948-952.
12. Ferrario CM, Chappell MC, Dean RH, Iyer SN, (1998). Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis. J Am Soc Nephrol 9: 1716-1722. (Pubitemid 28405080)
13. Gomes ER, Lara AA, Almeida PW, Guimaraes D, Resende RR, Campagnole-Santos MJ, et al,. (2010). Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3′,5′-cyclic monophosphate-dependent pathway. Hypertension 55: 153-160.
14. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, et al,. (2007). Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 292: H736-H742.
15. Hartley CJ, Reddy AK, Madala S, Martin-McNulty B, Vergona R, Sullivan ME, et al,. (2000). Hemodynamic changes in apolipoprotein E-knockout mice. Am J Physiol Heart Circ Physiol 279: H2326-H2334.
16. t Hoen PA, Van der Lans CA, Van Eck M, Bijsterbosch MK, Van Berkel TJ, Twisk J, (2003). Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res 93: 262-269. (Pubitemid 36993238)
17. Iusuf D, Henning RH, van Gilst WH, Roks AJ, (2008). Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives. Eur J Pharmacol 585: 303-312.
18. Kostenis E, Milligan G, Christopoulos A, Sanchez-Ferrer CF, Heringer-Walther S, Sexton PM, et al,. (2005). G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111: 1806-1813. (Pubitemid 40525146)
19. Laursen JB, Boesgaard S, Trautner S, Rubin I, Poulsen HE, Aldershvile J, (2001). Endothelium-dependent vasorelaxation in inhibited by in vivo depletion of vascular thiol levels: role of endothelial nitric oxide synthase. Free Radic Res 35: 387-394. (Pubitemid 32894357)
20. Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, Boomsma F, et al,. (2002). Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105: 1548-1550. (Pubitemid 34297630)
21. Lovren F, Pan Y, Quan A, Teoh H, Wang G, Shukla PC, et al,. (2008). Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J Physiol Heart Circ Physiol 295: H1377-H1384.
22. Mehta PK, Griendling KK, (2007). Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-C97. (Pubitemid 46127306)
23. Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, et al,. (2008). Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res 103: 1319-1326.
24. Osada J, Joven J, Maeda N, (2000). The value of apolipoprotein E knockout mice for studying the effects of dietary fat and cholesterol on atherogenesis. Curr Opin Lipidol 11: 25-29. (Pubitemid 30148194)
25. Patzak A, Steege A, Lai EY, Brinkmann JO, Kupsch E, Spielmann N, et al,. (2008). Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 294: R429-R437. (Pubitemid 351213747)
26. Peiro C, Vallejo S, Gembardt F, Azcutia V, Heringer-Walther S, Rodriguez-Manas L, et al,. (2007). Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function. J Hypertens 25: 2421-2425. (Pubitemid 350060381)
27. Pinheiro SV, Ferreira AJ, Kitten GT, da Silveira KD, da Silva DA, Santos SH, et al,. (2009). Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. Kidney Int 75: 1184-1193.
28. Polizio AH, Gironacci MM, Tomaro ML, Pena C, (2007). Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production. Pharmacol Res 56: 86-90. (Pubitemid 46990932)
29. Rabelo LA, Xu P, Todiras M, Sampaio WO, Buttgereit J, Bader M, et al,. (2008). Ablation of angiotensin (1-7) receptor Mas in C57Bl/6 mice causes endothelial dysfunction. J Am Soc Hypertens 2: 418-424.
30. Rentzsch B, Todiras M, Iliescu R, Popova E, Campos LA, Oliveira ML, et al,. (2008). Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 52: 967-973.
31. Sampaio WO, Henrique de Castro C, Santos RA, Schiffrin EL, Touyz RM, (2007a). Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50: 1093-1098. (Pubitemid 350172931)
32. Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM, (2007b). Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49: 185-192. (Pubitemid 46360359)
33. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, et al,. (2003). Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100: 8258-8263. (Pubitemid 36842532)
34. Santos SH, Fernandes LR, Mario EG, Ferreira AV, Porto LC, Alvarez-Leite JI, et al,. (2008). Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 57: 340-347.
35. Stegbauer J, Vonend O, Oberhauser V, Rump LC, (2003). Effects of angiotensin-(1-7) and other bioactive components of the renin-angiotensin system on vascular resistance and noradrenaline release in rat kidney. J Hypertens 21: 1391-1399.
36. Stegbauer J, Oberhauser V, Vonend O, Rump LC, (2004). Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats. Cardiovasc Res 61: 352-359. (Pubitemid 38091775)
37. Stegbauer J, Vonend O, Habbel S, Quack I, Sellin L, Gross V, et al,. (2005). Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice. J Hypertens 23: 1691-1698. (Pubitemid 41233429)
38. Wassmann S, Czech T, van Eickels M, Fleming I, Bohm M, Nickenig G, (2004). Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 110: 3062-3067. (Pubitemid 39491999)
39. Xu H, Fink GD, Galligan JJ, (2004). Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2- in DOCA-salt rats. Hypertension 43: 329-334. (Pubitemid 38174134)
40. Xu P, Costa-Goncalves AC, Todiras M, Rabelo LA, Sampaio WO, Moura MM, et al,. (2008). Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice. Hypertension 51: 574-580. (Pubitemid 351156450)